6CM
FOMX

683 Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

683 Capital Management’s Portfolio FOMX Stock Details FOMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-375,100
Closed -$1.25M – 206
2019
Q4 		$1.25M Buy
+375,100
New +$1.19M 0.14% 67

683 Capital Management's FOMX Position: Q1 2020 in Review

683 Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 375,100 shares — an estimated $1.25M sold.

683 Capital Management first reported a position in FOMX in Q4 2019 and held it in 1 quarter. The position peaked at $1.25M in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

  • 683 Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
  • 683 Capital Management sold 375,100 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $1.25M.
  • 683 Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q4 2019 and held it in 1 quarter.
  • 683 Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $1.25M in Q4 2019.
  • 3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on 683 Capital Management's 13F filing for Q1 2020, filed 15 May 2020.